<DOC>
	<DOCNO>NCT00257816</DOCNO>
	<brief_summary>There approximately 14,000 new patient invasive cervical cancer diagnose United States 2003 4,000 death disease . This account approximately 17 % death due gynecologic cancer . Radiation primary treatment modality locoregionally advanced cervical cancer . Recent trial concomitant systemic cisplatin chemotherapy radiation show high response rate ( RR ) improvements durable remission overall survival . Though incidence mortality U.S. drop steadily year 1940 2000 , recently plateau , arrest decline . With routine addition systemic Cisplatin ( CDDP ) chemotherapy local regional radiation , mortality advance cervical cancer United States expect decrease . However , advance disease need .</brief_summary>
	<brief_title>Weekly IV Topotecan Cisplatin With Radiation Cervical Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>1 . Patients primary , previously untreated , histologically confirm invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma uterine cervix , Stage I2 , IIB , IIIB , IVA . 2 . Patients negative , nonsuspicious paraaortic node determine lymphangiogram , CT , MRI lymphadenectomy . 3 . Patients adequate bone marrow function : ANC great equal 1,500/mcl , platelet great equal 100,000/mcl , Hemoglobin &gt; 10 mg/dl . 4 . Patients adequate renal function : Creatinine equal less 1.5 mg % . 5 . Patients adequate hepatic function : Bilirubin le equal 1.5 x normal SGOT Alkaline phosphatase less equal 3 x normal . 6 . Patients sign approve informed consent . 7 . Patients GOG Performance Status 0 , 1 , 2 , 3 . 8 . Patients childbearing potential must negative serum pregnancy test use effective form contraception . 9 . Patients suitable treatment radical intent use concurrent cisplatin pelvic radiation . 1 . Patients adequately clinically stag . 2 . Patients low onethird vaginal involvement . 3 . Patients septicemia severe infection . 4 . Patients circumstance permit completion study require followup . 5 . Patients invasive malignancy , exception nonmelanoma skin cancer , ( ) evidence cancer present within last 5 year whose previous cancer treatment contraindicate protocol therapy . 6 . Patients carcinoma cervical stump . 7 . Patients lactate pregnant .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Cervical Cancer</keyword>
</DOC>